ALDA Pharmaceuticals Corp. (TSX VENTURE:APH) ("the Company" or "ALDA") announces that a new DIN (02321424) has been issued by Health Canada for T36(R) Antiseptic Hand Sanitizer in liquid form. This new product complements ALDA's previously approved T36(R) Antiseptic Hand Sanitizer Gel and allows the formulation to be manufactured and sold as a spray.

Compared to typical alcohol-based hand sanitizers, ALDA's T36(R) Antiseptic Hand Sanitizer is a unique formula with two active ingredients that provide faster action against a broader range of infectious organisms and offer a long-lasting residual effect.

About ALDA Pharmaceuticals

ALDA is focused on the development of infection-control therapeutics derived from its patented T36(R) technology. The company trades on the TSX Venture Exchange under the symbol APH.

Terrance G. Owen, Ph.D., MBA, President & CEO

ALDA Pharmaceuticals Corp.

SOURCE: ALDA Pharmaceuticals Corp.

ALDA Pharmaceuticals Corp. Peter Chen Distribution & Sales Contact (604) 521-8300 Ext. 3 (604) 521-8322 (FAX) Email: peter_chen@aldacorp.com ALDA Pharmaceuticals Corp. Scott Young Investor Relations Contact (604) 288-7222 Email: syoung@freeformcom.com Website: www.aldacorp.com